Sim&Cure

📍 Montpellier, France🗓 Founded 2014👥 63 employees💰 Last funded Mar 2025
Founded in 2014 and located in the vibrant Medtech ecosystem in Montpellier, France, Sim&Cure is a digital start-up focused on Improving patient outcome and physician experience of endovascular treatment by combining Digital Twin and AI Technologies. As new technologies progress through the medical network, S&C will help its partners to flatten the learning curve. Sim&Cures philosophy focuses on driving innovation in the healthcare industry and helping to improve treatments strategies in order to secure patient care. Sim&Cure has won the prestigious i-Lab national contest twice in 2014 and 2015 and i-Nov in 2020. The start-up is backed by the Seed Fund IT-Translation and Elaia Partners Sim&Cure has established scientific and clinical collaborations with leading laboratories and hospitals around the world. Sim&Cure opened a subsidiary in US (NY) in July 2019. The company employs 50 people and anticipates a phase of strong growth.
3
Total investors
0
Early stage
2
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
France
3
Investor activity2019–2025 · investors recorded per year
2019220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sim&Cure?
Sim&Cure has 3 investors on record on gritt.io, 2 mid-stage.
When did Sim&Cure last raise funding?
The most recent investment in Sim&Cure recorded on gritt.io was in March 2025.
When was Sim&Cure founded?
Sim&Cure was founded in 2014.
What industry is Sim&Cure in?
Sim&Cure operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sim&Cure based?
Sim&Cure is headquartered in Montpellier, France.